Small and large intestinal cancer in patients with Crohn's disease studied by surgeons.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 06 06 2022
accepted: 18 09 2022
medline: 29 5 2023
pubmed: 27 10 2022
entrez: 26 10 2022
Statut: ppublish

Résumé

The current study summarized the clinical course and treatment outcomes of intestinal cancer in CD seen in our department and explored the steps to take in the future. Subjects were patients who had been diagnosed with CD at our hospital and who underwent surgery in our department from 1985 to 2020. Thirty-one patients had CD and intestinal cancer, including 6 with cancer of the small intestine and 25 with cancer of the large intestine. In all six patients with cancer of the small intestine, the site where cancer or a tumor developed was at or near the site of the anastomosis made at a previous surgery. Of the 25 patients with cancer of the large intestine, 22 developed cancer in the rectum or anal region. Many of the patients with cancer of the small intestine had previously undergone surgery, and the cancer developed at or near the site of the anastomosis. In patients who have previously undergone resection of the small intestine, the small intestine needs to be examined regularly. Cancer of the large intestine often developed in the rectum or anal region of our patients, so a detailed examination of the same site needs to be performed.

Identifiants

pubmed: 36289073
doi: 10.1007/s00595-022-02605-5
pii: 10.1007/s00595-022-02605-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

675-680

Informations de copyright

© 2022. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

Références

Yano Y, Matsui T, Hirai F, Okado Y, Sato Y, Tsurumi K, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.
doi: 10.1111/jgh.12189 pubmed: 23488881
Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.
doi: 10.1159/000273784 pubmed: 20134166
Korelitz BI. Carcinoma of the intestinal tract in Crohn’s disease: results of survey conducted by the National Foundation for Ileitis and colitis. Am J Gastroenterol. 1983;78:44–6.
pubmed: 6849315
Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn’s disease. Gut. 1980;21:1024–9.
doi: 10.1136/gut.21.12.1024 pubmed: 7461462 pmcid: 1419401
Von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.
doi: 10.1007/s10350-006-0848-z
Yano Y, Matsui T, Uno H, Hirai F, Futami K, Iwashita A. Risks and clinical features of colorectal cancer complicating Crohn’s disease in Japanese patients. J Gastroenterol Hepatol. 2008;23:1683–8.
doi: 10.1111/j.1440-1746.2008.05532.x pubmed: 18752557
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.
doi: 10.1111/j.1365-2036.2006.02854.x pubmed: 16611269
Higashi D, Futami K, Kojima D, Futatsuki R, Ishibashi Y, Maekawa T, et al. Cancer of the small intestine in patients with Crohn’s disease. Anticancer Res. 2013;33:2977–80.
pubmed: 23780989
Kiran RP, Nisar PJ, Goldblum JR, Fazio VW, Remzi FH, Shen B, et al. Dysplasia associated with Crohn’s colitis: segmental colectomy or more extended resection? Ann Surg. 2012;256:221–6.
doi: 10.1097/SLA.0b013e31825f0709 pubmed: 22791098
Choi PM, Zeling MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950–4.
doi: 10.1136/gut.35.7.950 pubmed: 8063223 pmcid: 1374843
Stahl TJ, Schoetz DJ Jr, Roberts PL, Coller JA, Murray JJ, Silverman ML, et al. Crohn’s disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum. 1992;35:850–6.
doi: 10.1007/BF02047872 pubmed: 1511645
Higashi D, Katsuno H, Kimura H, Takahashi K, Ikeuchi H, Kono T, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36:3761–6.
pubmed: 27354651
Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part3; special situations. J Crohns Coitis. 2013;7:1–33.
doi: 10.1016/j.crohns.2012.09.005
Matsumoto T, Iwao Y, Igarashi M, Watanabe K, Otsuka K, Watanabe T, et al. Endoscopic and Chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis. 2008;14:259–64.
doi: 10.1002/ibd.20267 pubmed: 17973300
Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45.
doi: 10.1053/j.gastro.2009.12.037 pubmed: 20141808
Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. BR J Cacner. 2003;89:1232–6.
doi: 10.1038/sj.bjc.6601247
Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med. 2004;3:209–23.
doi: 10.1053/j.semnuclmed.2004.03.006
Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7–17.
doi: 10.1152/ajpgi.00079.2004 pubmed: 15194558
Hirano Y, Futami K, Higashi D, Mikami K, Maekawa T. Anorectal cancer surveillance in Crohn’s disease. J Anus Rectum Colon. 2018;2(4):145–54.
doi: 10.23922/jarc.2018-005 pubmed: 31559357 pmcid: 6752139

Auteurs

Daijiro Higashi (D)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan. Daijiro@fukuoka-u.ac.jp.

Hisatoshi Irie (H)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Toshimitsu Maki (T)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Hiroshi Kusaba (H)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Nobuhiko Koreeda (N)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Yosuke Hirano (Y)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Hiroki Kaida (H)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Makoto Kawamoto (M)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Akira Komono (A)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Hiroyuki Takahashi (H)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Rohei Sakamoto (R)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Ryosuke Shibata (R)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Yoshihiro Miyasaka (Y)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Takashi Hisabe (T)

Department of Inflammatory Bowel Disease Center, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Satoshi Nimura (S)

Department of Pathology, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Masato Watanabe (M)

Department of Surgery, Chikushi Hospital, Fukuoka University, Chikusino-shi, 818-8502, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH